Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation

D. A. Stewart, D. Guo, S. Glück, D. Morris, A. Chaudhry, C. Demetz, J. Klassen, C. B. Brown, J. A. Russell

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences